Serum Retinol-Binding Protein 4 Levels in Patients with Diabetic Retinopathy

Abstract

Retinol-binding protein 4 (RBP4) has been reported to be involved in the development of insulin resistance and diabetes. This study was designed to investigate serum levels of RBP4 in patients with type 2 diabetes with and without diabetic retinopathy. Based on ophthalmological examination, 92 patients with type 2 diabetes were divided into three subgroups: those without diabetic retinopathy (NDR; n = 40); those with simple diabetic retinopathy (SDR; n = 37); and those with proliferative diabetic retinopathy (PDR; n = 15). The serum RBP4 level was significantly elevated in individuals with PDR compared with those with NDR or SDR. There was a significant positive correlation between serum RBP4 level and the urine albumin excretion rate (r = 0.219). This study showed that RBP4 may be involved in the process of diabetic retinopathy and may be a novel biomarker for its diagnosis and treatment in diabetic patients.

Keywords

Type 2 diabetes mellitus Insulin resistance Diabetic retinopathy Proliferative diabetic retinopathy Retinol-binding protein 4

References

Aiello

Gardner

King

: Diabetic retinopathy. Diabetes Care 1998; 21: 143–156.

Yokoi

Yamagishi

Takeuchi

: Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy. Br J Ophthalmol 2005; 89: 673–675.

Adamis

: Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 2002; 86: 363–365.

Yang

Graham

Mody

: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356–362.

Graham

Yang

Bluher

: Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354: 2552–2563.

Takebayashi

Suetsugu

Wakabayashi

: Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007; 92: 2712–2719.

Jia

Bao

: Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 2007; 92: 3224–3229.

Balagopal

Graham

Kahn

: Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: Association with subclinical inflammation. J Clin Endocrinol Metab 2007; 92: 1971–1974.

Jia

Bao

: Association of serum retinol binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 2007; 92: 3224–3229.

10.

: Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 2007; 92: 4827–4834.

11.

Muoio

Newgard

: Metabolism: A is for adipokine. Nature 2005; 436: 337–338.

12.

Broch

Vendrell

Ricart

: Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care 2007; 30: 1802–1806.

13.

von Eynatten

Lepper

Liu

: Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007; 50: 1930–1937.

14.

Takebayashi

Suetsugu

Wakabayashi

: Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007; 92: 2712–2719.

15.

Raila

Henze

Spranger

: Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients. Kidney Int 2007; 72: 505–511.

16.

Kalani

: The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag 2008; 4: 1061–1068.

17.

Qaum

Joussen

: VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 2002; 42: 2408–2413.